Skip to content

Trial evidence / Filing Seasonal Common Income Change

B617ee32069d2f7f

Hypothesis key b617ee32069d2f7f Complete

First measurementNot recordedThis identity carries no first-measurement Sharpe. It is one of 4 such identities.

Forward epoch

Measured after the legacy epoch closed, under reservation ordinal 330. Register status DEVELOPMENT CLOSURE FINAL NOT ADMITTED. Final disposition KILL, not admitted: a development closure: the decision the study that ran this identity already made, imported and recorded, computing nothing.

Not ranked in the legacy distribution: that population is the retired epoch, and this identity belongs to the one after it.

Immutable first measurement

Hypothesis key
b617ee32069d2f7f
Configuration hash
6cd2a49aa4cf2ee4
Research family
Filing Seasonal Common Income Change
Packet status
COMPLETE_ACCOUNTING_FINAL_KILLED_NOT_ADMITTED
Observations
857
Annualized Sharpe
-0.2379186
Skew
-0.5862843
Kurtosis
8.046115

Evidence coverage

  1. Admission Or Kill Decision

    verified
    • Evidence23e655a3f37e66b6db89a9da1c756e5e96a8a0d3991c0cd3eae3b4851a4e5f9e
    • Evidence4c368b83ac84808f9cbaaf6fd9e93c099234cdc796f3450543c4b375f8ae4f02
    • Evidence00e55e4f563f7e7e4697b720031d5a73c6dee2796dad5fc60ee74c7cfe2e6036
    • Evidence861828be0bdc78df7a86f3a1d8024dae110fed1486e849d42584adf1aec7eb58
    • Evidencec053c9755873783ef5434935ba99d2320f8e5354244eea4d67c7035493eee035
    • Evidencede8ba364f058cb92d905db19fb80048804de9f28534d92e39a2609a4584d6151
    • Evidence428a26529ddc130e3274a4beee236c3492325e8ac84dd804ea357aa7403c0bb7
    • Evidence35fd5831186004ef77e47c832b11cd0da52f0150912984ccd633ef859cc4b908
    • Evidence3f59ec0ccd0994db1966767cb4bb17fee3c944fa3a54372541efdad3e2ac3a81
    • Evidencec9ecd143db300eecdea576233a5fda941e1d699419b92419404d6a25ca610f0f
    • Evidencee34606174c6e8b0f0c687dc4683b8a0ac3aa11ad7a498b029dacaa7e7b17d930
    • Evidence85d4b19d38db9c9cf2be2698ea34289e53b13a8724f6d03b1ab6bcbc760b22a3
    • Final Development Admission Closure203f5e1aa31e3404cef836e4d16862d18e9a94fc2fa5e55a78ab708206eb6f5f
  2. Code Environment And Reproduction

    verified
    • Evidence23e655a3f37e66b6db89a9da1c756e5e96a8a0d3991c0cd3eae3b4851a4e5f9e
    • Evidence4c368b83ac84808f9cbaaf6fd9e93c099234cdc796f3450543c4b375f8ae4f02
    • Evidence00e55e4f563f7e7e4697b720031d5a73c6dee2796dad5fc60ee74c7cfe2e6036
    • Evidence861828be0bdc78df7a86f3a1d8024dae110fed1486e849d42584adf1aec7eb58
    • Evidencec053c9755873783ef5434935ba99d2320f8e5354244eea4d67c7035493eee035
    • Evidencede8ba364f058cb92d905db19fb80048804de9f28534d92e39a2609a4584d6151
    • Evidence428a26529ddc130e3274a4beee236c3492325e8ac84dd804ea357aa7403c0bb7
    • Evidence35fd5831186004ef77e47c832b11cd0da52f0150912984ccd633ef859cc4b908
    • Evidence3f59ec0ccd0994db1966767cb4bb17fee3c944fa3a54372541efdad3e2ac3a81
    • Evidencec9ecd143db300eecdea576233a5fda941e1d699419b92419404d6a25ca610f0f
    • Evidencee34606174c6e8b0f0c687dc4683b8a0ac3aa11ad7a498b029dacaa7e7b17d930
    • Evidence85d4b19d38db9c9cf2be2698ea34289e53b13a8724f6d03b1ab6bcbc760b22a3
  3. Economic Mechanism And Falsifiable Hypothesis

    verified
    • Evidence23e655a3f37e66b6db89a9da1c756e5e96a8a0d3991c0cd3eae3b4851a4e5f9e
    • Evidence4c368b83ac84808f9cbaaf6fd9e93c099234cdc796f3450543c4b375f8ae4f02
    • Evidence00e55e4f563f7e7e4697b720031d5a73c6dee2796dad5fc60ee74c7cfe2e6036
    • Evidence861828be0bdc78df7a86f3a1d8024dae110fed1486e849d42584adf1aec7eb58
    • Evidencec053c9755873783ef5434935ba99d2320f8e5354244eea4d67c7035493eee035
    • Evidencede8ba364f058cb92d905db19fb80048804de9f28534d92e39a2609a4584d6151
    • Evidence428a26529ddc130e3274a4beee236c3492325e8ac84dd804ea357aa7403c0bb7
    • Evidence35fd5831186004ef77e47c832b11cd0da52f0150912984ccd633ef859cc4b908
    • Evidence3f59ec0ccd0994db1966767cb4bb17fee3c944fa3a54372541efdad3e2ac3a81
    • Evidencec9ecd143db300eecdea576233a5fda941e1d699419b92419404d6a25ca610f0f
    • Evidencee34606174c6e8b0f0c687dc4683b8a0ac3aa11ad7a498b029dacaa7e7b17d930
    • Evidence85d4b19d38db9c9cf2be2698ea34289e53b13a8724f6d03b1ab6bcbc760b22a3
  4. Execution And Cost Model

    verified
    • Evidence23e655a3f37e66b6db89a9da1c756e5e96a8a0d3991c0cd3eae3b4851a4e5f9e
    • Evidence4c368b83ac84808f9cbaaf6fd9e93c099234cdc796f3450543c4b375f8ae4f02
    • Evidence00e55e4f563f7e7e4697b720031d5a73c6dee2796dad5fc60ee74c7cfe2e6036
    • Evidence861828be0bdc78df7a86f3a1d8024dae110fed1486e849d42584adf1aec7eb58
    • Evidencec053c9755873783ef5434935ba99d2320f8e5354244eea4d67c7035493eee035
    • Evidencede8ba364f058cb92d905db19fb80048804de9f28534d92e39a2609a4584d6151
    • Evidence428a26529ddc130e3274a4beee236c3492325e8ac84dd804ea357aa7403c0bb7
    • Evidence35fd5831186004ef77e47c832b11cd0da52f0150912984ccd633ef859cc4b908
    • Evidence3f59ec0ccd0994db1966767cb4bb17fee3c944fa3a54372541efdad3e2ac3a81
    • Evidencec9ecd143db300eecdea576233a5fda941e1d699419b92419404d6a25ca610f0f
    • Evidencee34606174c6e8b0f0c687dc4683b8a0ac3aa11ad7a498b029dacaa7e7b17d930
    • Evidence85d4b19d38db9c9cf2be2698ea34289e53b13a8724f6d03b1ab6bcbc760b22a3
  5. Family And Union Trial Accounting

    verified
    • Evidence23e655a3f37e66b6db89a9da1c756e5e96a8a0d3991c0cd3eae3b4851a4e5f9e
    • Evidence4c368b83ac84808f9cbaaf6fd9e93c099234cdc796f3450543c4b375f8ae4f02
    • Evidence00e55e4f563f7e7e4697b720031d5a73c6dee2796dad5fc60ee74c7cfe2e6036
    • Evidence861828be0bdc78df7a86f3a1d8024dae110fed1486e849d42584adf1aec7eb58
    • Evidencec053c9755873783ef5434935ba99d2320f8e5354244eea4d67c7035493eee035
    • Evidencede8ba364f058cb92d905db19fb80048804de9f28534d92e39a2609a4584d6151
    • Evidence428a26529ddc130e3274a4beee236c3492325e8ac84dd804ea357aa7403c0bb7
    • Evidence35fd5831186004ef77e47c832b11cd0da52f0150912984ccd633ef859cc4b908
    • Evidence3f59ec0ccd0994db1966767cb4bb17fee3c944fa3a54372541efdad3e2ac3a81
    • Evidencec9ecd143db300eecdea576233a5fda941e1d699419b92419404d6a25ca610f0f
    • Evidencee34606174c6e8b0f0c687dc4683b8a0ac3aa11ad7a498b029dacaa7e7b17d930
    • Evidence85d4b19d38db9c9cf2be2698ea34289e53b13a8724f6d03b1ab6bcbc760b22a3
  6. Identity And Authorship

    verified
    • Evidence23e655a3f37e66b6db89a9da1c756e5e96a8a0d3991c0cd3eae3b4851a4e5f9e
    • Evidence4c368b83ac84808f9cbaaf6fd9e93c099234cdc796f3450543c4b375f8ae4f02
    • Evidence00e55e4f563f7e7e4697b720031d5a73c6dee2796dad5fc60ee74c7cfe2e6036
    • Evidence861828be0bdc78df7a86f3a1d8024dae110fed1486e849d42584adf1aec7eb58
    • Evidencec053c9755873783ef5434935ba99d2320f8e5354244eea4d67c7035493eee035
    • Evidencede8ba364f058cb92d905db19fb80048804de9f28534d92e39a2609a4584d6151
    • Evidence428a26529ddc130e3274a4beee236c3492325e8ac84dd804ea357aa7403c0bb7
    • Evidence35fd5831186004ef77e47c832b11cd0da52f0150912984ccd633ef859cc4b908
    • Evidence3f59ec0ccd0994db1966767cb4bb17fee3c944fa3a54372541efdad3e2ac3a81
    • Evidencec9ecd143db300eecdea576233a5fda941e1d699419b92419404d6a25ca610f0f
    • Evidencee34606174c6e8b0f0c687dc4683b8a0ac3aa11ad7a498b029dacaa7e7b17d930
    • Evidence85d4b19d38db9c9cf2be2698ea34289e53b13a8724f6d03b1ab6bcbc760b22a3
  7. Literature And Overlap Decision

    verified
    • Evidence23e655a3f37e66b6db89a9da1c756e5e96a8a0d3991c0cd3eae3b4851a4e5f9e
    • Evidence4c368b83ac84808f9cbaaf6fd9e93c099234cdc796f3450543c4b375f8ae4f02
    • Evidence00e55e4f563f7e7e4697b720031d5a73c6dee2796dad5fc60ee74c7cfe2e6036
    • Evidence861828be0bdc78df7a86f3a1d8024dae110fed1486e849d42584adf1aec7eb58
    • Evidencec053c9755873783ef5434935ba99d2320f8e5354244eea4d67c7035493eee035
    • Evidencede8ba364f058cb92d905db19fb80048804de9f28534d92e39a2609a4584d6151
    • Evidence428a26529ddc130e3274a4beee236c3492325e8ac84dd804ea357aa7403c0bb7
    • Evidence35fd5831186004ef77e47c832b11cd0da52f0150912984ccd633ef859cc4b908
    • Evidence3f59ec0ccd0994db1966767cb4bb17fee3c944fa3a54372541efdad3e2ac3a81
    • Evidencec9ecd143db300eecdea576233a5fda941e1d699419b92419404d6a25ca610f0f
    • Evidencee34606174c6e8b0f0c687dc4683b8a0ac3aa11ad7a498b029dacaa7e7b17d930
    • Evidence85d4b19d38db9c9cf2be2698ea34289e53b13a8724f6d03b1ab6bcbc760b22a3
  8. Machine Readable Packet And Stable Public Paper

    verified
    • Evidence23e655a3f37e66b6db89a9da1c756e5e96a8a0d3991c0cd3eae3b4851a4e5f9e
    • Evidence4c368b83ac84808f9cbaaf6fd9e93c099234cdc796f3450543c4b375f8ae4f02
    • Evidence00e55e4f563f7e7e4697b720031d5a73c6dee2796dad5fc60ee74c7cfe2e6036
    • Evidence861828be0bdc78df7a86f3a1d8024dae110fed1486e849d42584adf1aec7eb58
    • Evidencec053c9755873783ef5434935ba99d2320f8e5354244eea4d67c7035493eee035
    • Evidencede8ba364f058cb92d905db19fb80048804de9f28534d92e39a2609a4584d6151
    • Evidence428a26529ddc130e3274a4beee236c3492325e8ac84dd804ea357aa7403c0bb7
    • Evidence35fd5831186004ef77e47c832b11cd0da52f0150912984ccd633ef859cc4b908
    • Evidence3f59ec0ccd0994db1966767cb4bb17fee3c944fa3a54372541efdad3e2ac3a81
    • Evidencec9ecd143db300eecdea576233a5fda941e1d699419b92419404d6a25ca610f0f
    • Evidencee34606174c6e8b0f0c687dc4683b8a0ac3aa11ad7a498b029dacaa7e7b17d930
    • Evidence85d4b19d38db9c9cf2be2698ea34289e53b13a8724f6d03b1ab6bcbc760b22a3
  9. Point In Time Data And Survivorship Controls

    verified
    • Evidence23e655a3f37e66b6db89a9da1c756e5e96a8a0d3991c0cd3eae3b4851a4e5f9e
    • Evidence4c368b83ac84808f9cbaaf6fd9e93c099234cdc796f3450543c4b375f8ae4f02
    • Evidence00e55e4f563f7e7e4697b720031d5a73c6dee2796dad5fc60ee74c7cfe2e6036
    • Evidence861828be0bdc78df7a86f3a1d8024dae110fed1486e849d42584adf1aec7eb58
    • Evidencec053c9755873783ef5434935ba99d2320f8e5354244eea4d67c7035493eee035
    • Evidencede8ba364f058cb92d905db19fb80048804de9f28534d92e39a2609a4584d6151
    • Evidence428a26529ddc130e3274a4beee236c3492325e8ac84dd804ea357aa7403c0bb7
    • Evidence35fd5831186004ef77e47c832b11cd0da52f0150912984ccd633ef859cc4b908
    • Evidence3f59ec0ccd0994db1966767cb4bb17fee3c944fa3a54372541efdad3e2ac3a81
    • Evidencec9ecd143db300eecdea576233a5fda941e1d699419b92419404d6a25ca610f0f
    • Evidencee34606174c6e8b0f0c687dc4683b8a0ac3aa11ad7a498b029dacaa7e7b17d930
    • Evidence85d4b19d38db9c9cf2be2698ea34289e53b13a8724f6d03b1ab6bcbc760b22a3
  10. Preregistration And Hashes

    verified
    • Evidence23e655a3f37e66b6db89a9da1c756e5e96a8a0d3991c0cd3eae3b4851a4e5f9e
    • Evidence4c368b83ac84808f9cbaaf6fd9e93c099234cdc796f3450543c4b375f8ae4f02
    • Evidence00e55e4f563f7e7e4697b720031d5a73c6dee2796dad5fc60ee74c7cfe2e6036
    • Evidence861828be0bdc78df7a86f3a1d8024dae110fed1486e849d42584adf1aec7eb58
    • Evidencec053c9755873783ef5434935ba99d2320f8e5354244eea4d67c7035493eee035
    • Evidencede8ba364f058cb92d905db19fb80048804de9f28534d92e39a2609a4584d6151
    • Evidence428a26529ddc130e3274a4beee236c3492325e8ac84dd804ea357aa7403c0bb7
    • Evidence35fd5831186004ef77e47c832b11cd0da52f0150912984ccd633ef859cc4b908
    • Evidence3f59ec0ccd0994db1966767cb4bb17fee3c944fa3a54372541efdad3e2ac3a81
    • Evidencec9ecd143db300eecdea576233a5fda941e1d699419b92419404d6a25ca610f0f
    • Evidencee34606174c6e8b0f0c687dc4683b8a0ac3aa11ad7a498b029dacaa7e7b17d930
    • Evidence85d4b19d38db9c9cf2be2698ea34289e53b13a8724f6d03b1ab6bcbc760b22a3
  11. Result Uncertainty Stress Capacity And Diversification

    verified
    • Evidence23e655a3f37e66b6db89a9da1c756e5e96a8a0d3991c0cd3eae3b4851a4e5f9e
    • Evidence4c368b83ac84808f9cbaaf6fd9e93c099234cdc796f3450543c4b375f8ae4f02
    • Evidence00e55e4f563f7e7e4697b720031d5a73c6dee2796dad5fc60ee74c7cfe2e6036
    • Evidence861828be0bdc78df7a86f3a1d8024dae110fed1486e849d42584adf1aec7eb58
    • Evidencec053c9755873783ef5434935ba99d2320f8e5354244eea4d67c7035493eee035
    • Evidencede8ba364f058cb92d905db19fb80048804de9f28534d92e39a2609a4584d6151
    • Evidence428a26529ddc130e3274a4beee236c3492325e8ac84dd804ea357aa7403c0bb7
    • Evidence35fd5831186004ef77e47c832b11cd0da52f0150912984ccd633ef859cc4b908
    • Evidence3f59ec0ccd0994db1966767cb4bb17fee3c944fa3a54372541efdad3e2ac3a81
    • Evidencec9ecd143db300eecdea576233a5fda941e1d699419b92419404d6a25ca610f0f
    • Evidencee34606174c6e8b0f0c687dc4683b8a0ac3aa11ad7a498b029dacaa7e7b17d930
    • Evidence85d4b19d38db9c9cf2be2698ea34289e53b13a8724f6d03b1ab6bcbc760b22a3

Completion assessment

COMPLETE_ACCOUNTING_FINAL_KILLED_NOT_ADMITTED

Frozen configuration

Allocation
20long20short equal2.5percent;40eligible minimum;lexicographicstableIDties
Allocator
earnings_monthly_equal_notional
Alpha Names
filing_seasonal_common_income_change_v1
Combined
10percentcandidate fromcash;22.5percenteachreference316/317subbook
Cost Arm
normal
Cost Sigma Basis
split_corrected_log_returns_v1
End
1,780,444,800,000
Evaluation
Jan1 2023 throughJune1 2026 source sessions, combined fullUTCcalendar
Failure Policy
stop formula/allocation family; no denominator/holding/width/sign/weight sweep
Formula
(netinccmn_current-netinccmn_same_fiscal_quarter_prior_year)/assets_prior_pair
Gates
{"annual_excess_floor_delta":-0.25,"combined_excess_gain_each":0.1,"combined_full_and_annual_dd_max":0.11,"combined_return_not_lower":true,"standalone_excess_positive_both":true}
Initial Cash
100,000
Input Manifest Sha256
e34606174c6e8b0f0c687dc4683b8a0ac3aa11ad7a498b029dacaa7e7b17d930
Instrument Ids
List preserved in the machine-readable packet
Limitations
historical membership/metadata modeled, dividendpay ex+nextsession modeled, static borrow not observed availability, Cost sigma split-corrected using frozen retrospective action ratios; historical action availability not certified, fixed combined subbook curve not integrated executable book
No Trade Band
0.001
Rebalance
monthly firstsourceopen/priorphysicalclose
Resolved Costs
{"default_half_spread_bps":2.5,"equity_borrow_bps_annual":50,"equity_commission_bps":1,"equity_half_spread_bps":3,"impact_coef":1,"latency_addon_bps":2,"perp_maker_bps":2,"perp_taker_bps":5}
Risk
half10percent flat15percent cooldown10sessions;recoverymonthly
Scope
retrospective continuous research, not untouched OOS
Start
1,672,272,000,000

Verify the packet

Download the machine-readable packet · All trials

Packet content hash sha256:48bfc734147be163cf63404cb5a18dd923a189c5ae5ae013996c4c7e86f8b72a